Clinical Trials in Detroit

Showing 11581-11600 of 16,931 trials

Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

NCT01656304

This pilot phase II trial studies how well giving bevacizumab works in treating patients with relapsed prostate cancer that did not respond to hormone therapy. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or tumor-killing substances to them. Bevacizumab may also stop the growth of prostate cancer by blocking blood flow to the tumor

Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more

Barbara Ann Karmanos Cancer Institute16 participantsStarted May 2007

Detroit, Michigan, United States • Detroit, Michigan, United States

COMPLETEDPhase 4< 1 mile

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

NCT01500278

This study is conducted to evaluate the short (12 Weeks) and long term (104 Weeks) efficacy of Certolizumab Pegol compared with Adalimumab both in combination with Methotrexate (MTX) in the treatment of moderate to severe Rheumatoid Arthritis (RA) that is not responding adequately to MTX.

Rheumatoid Arthritis

UCB Pharma SA915 participantsStarted Dec 2011

Birmingham, Alabama, United States • Tuscaloosa, Alabama, United States • Tucson, Arizona, United States +172 more locations

Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Find Trials by Condition in Detroit

Post Approval NovaSure Essure Labeling Study

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

COPE With COPD Trial

Sleep Therapy for Insomnia and Depression

TARGET Intracranial Aneurysm Coiling Registry

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Open Label Study of Long Term Safety Evaluation of Alirocumab

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Brentuximab Vedotin for Steroid Refractory GvHD

Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

Evaluation of Efficacy and Safety of E004 in Children With Asthma

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease